News out on Generex (GNBT).
Quite interesting that GNBT made a deal with one of the majors for one of their side products. Do you think this opens the door for a potentially more substantial deal with Oralyn in the not so distant future? Or perhaps for a cancer partnership? Anytime a major takes an interest I always assume they have larger interests such as providing funds to further research and testing.Ann-Marie